Neuroone Medical Technologies Corp (NMTC): R&D Expense
$4.98M
Year ended 2025-09-30
$5.40M
Trailing 12 months to 2026-06-30
+0.4%
3-year compound annual growth
+19.1%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $4.98M | -1.6% | 2025-12-17, From 2024-10-01 |
| 2024-09-30 | $5.07M | -27.0% | 2025-12-17, From 2023-10-01 |
| 2023-09-30 | $6.94M | +40.8% | 2024-12-17, From 2022-10-01 |
| 2022-09-30 | $4.93M | +25.6% | 2023-12-15, From 2021-10-01 |
| 2021-09-30 | $3.93M | +89.1% | 2022-12-22, From 2020-10-01 |
| 2020-09-30 | $2.08M | +35.7% | 2022-05-31, From 2019-10-01 |
| 2019-09-30 | $1.53M | n/a | 2020-12-09, From 2018-10-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Neuroone Medical Technologies Corp (NMTC) | 2025-09-30 | $4.98M | -1.6% |
| InspireMD, Inc. (NSPR) | 2025-12-31 | $15.00M | +10.0% |
| Medinotec Inc. (MDNC) | 2026-02-28 | $149.9K | +64.4% |
| WORK Medical Technology Group LTD (WOK) | 2025-09-30 | $435.3K | +43.9% |
| Beyond Air, Inc. (XAIR) | 2026-03-31 | $10.24M | -39.2% |
| Nexgel, Inc. (NXGL) | 2025-12-31 | $2.0K | -97.4% |
| INVO Fertility, Inc. (IVF) | 2024-12-31 | $4.9K | -97.1% |
| Allurion Technologies, Inc. (ALUR) | 2025-12-31 | $7.57M | -56.4% |
| Cerenome, Inc. (CNSY) | 2025-12-31 | $8.38M | -20.8% |
Compare NMTC, NSPR, MDNC, WOK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗